Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Molecular Aspects of Co-morbidities in COVID-19 Infection.
2020
The “Three Italy” of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia
2020
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus
2020
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
2006
A structural perspective of the flavivirus life cycle
2004
Interaction of West Nile Virus with αvβ3 Integrin Mediates Virus Entry into Cells
2004
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
2020 Standout
Manipulation of cell surface macromolecules by flaviviruses
2003
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Novel insights into proteolytic cleavage of influenza virus hemagglutinin
2010
Interfering with hepatitis C virus RNA replication
2004 StandoutNobel
DC-SIGN: escape mechanism for pathogens
2003
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo
2008
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor
2003
High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I
2005
Receptors and routes of dengue virus entry into the host cells
2015
Contact with epithelial cells induces the formation of surface appendages on Salmonella typhimurium
1994
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Strategies for development of dengue virus inhibitors
2010
Cell entry of hepatitis C virus
2006
Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
2015
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
2019
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Use of mixed infections to study cell invasion and intracellular proliferation of Salmonella enterica in eukaryotic cell cultures
2003
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Adaptive Immunity to the Hepatitis C Virus
2010
Salmonella typhi uses CFTR to enter intestinal epithelial cells
1998 StandoutNatureNobel
Interclade Neutralization and Enhancement of Human Immunodeficiency Virus Type 1 Identified by an Assay Using HeLa Cells Expressing Both CD4 Receptor and CXCR4/CCR5 Coreceptors
2004 StandoutNobel
Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins
2004
Virus entry: molecular mechanisms and biomedical applications
2004
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement
2018 StandoutNobel
Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell
2009
New monoclonal anti-mouse DC-SIGN antibodies reactive with acetone-fixed cells
2010 StandoutNobel
Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus†
2005
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Hepatitis C Virus Entry
2007 StandoutNobel
Coronavirus Pathogenesis
2011
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
2014
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
2007
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
2009
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Hepatitis C virus infection: when silence is deception
2003
Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes
2005
HIV fusion and its inhibition
2001
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Pathogen Recognition and Innate Immunity
2006 Standout
SARS-CoV-2 vaccines in development
2020 StandoutNature
Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions
2004
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
2019
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers
2003
A Single-Amino-Acid Substitution in a Polymerase Protein of an H5N1 Influenza Virus Is Associated with Systemic Infection and Impaired T-Cell Activation in Mice
2009
Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway during Hepatitis C Virus Expression and Restoration of Signaling by IKKε
2005
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus
2006
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Hepatitis C Virus Entry
2013
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity
2007
cag , a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
1996 Standout
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus
2004
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Relationship between evolutionary rate and cellular location among the Inv/Spa invasion proteins of Salmonella enterica.
1995
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
2010
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus
2003
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I
2006
DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus
2004
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
2006
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
2012
Flavivirus Entry Receptors: An Update
2013
A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
2010
Rapid COVID-19 vaccine development
2020 Science
Hepatitis C virus entry: potential receptors and their biological functions
2006
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Adaptive strategies of the influenza virus polymerase for replication in humans
2009 StandoutNobel
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
DC-SIGN from African Green Monkeys Is Expressed in Lymph Nodes and Mediates Infection intransof Simian Immunodeficiency Virus SIVagm
2003 StandoutNobel
CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes
2008
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus
2006 StandoutNobel
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses
2006
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
A Novel Coronavirus from Patients with Pneumonia in China, 2019
2020 Standout
Structure, Function, and Evolution of Coronavirus Spike Proteins
2016 Standout
Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium.
1996
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
2011
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
Diverse CD81 Proteins Support Hepatitis C Virus Infection
2006 StandoutNobel
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding
2006
Cell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection
2004
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
2016
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Multivalent Ligand: Design Principle for Targeted Therapeutic Delivery Approach
2012
Prospects for the Future
2002 StandoutScienceNobel
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
2003 StandoutNobel
SALMONELLOSIS: Host Immune Responses and Bacterial Virulence Determinants1
1996
Works of Ralf Altmeyer being referenced
Virus Attachment and Entry Offer Numerous Targets for Antiviral Therapy
2004
Cloning and molecular characterization of a gene involved in Salmonella adherence and invasion of cultured epithelial cells
1993
C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles
2004
DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2
2003
Processing, Stability, and Receptor Binding Properties of Oligomeric Envelope Glycoprotein from a Primary HIV-1 Isolate
2000
Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro
2009
HIV-1 Entry into T-cells Is Not Dependent on CD4 and CCR5 Localization to Sphingolipid-enriched, Detergent-resistant, Raft Membrane Domains
2003
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro
2006
Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate
1997
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E
2005
SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.
2012
H5-Type Influenza Virus Hemagglutinin Is Functionally Recognized by the Natural Killer-Activating Receptor NKp44
2007
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway
2011
The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles
2008
Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses
2003